|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
|
|
|
|||||||||||||||||||||||||
| Test | 02-FEB-2019 | Reference Range | Unit |
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 5.9 | 4 - 6 | % |
| Glucose [Mass/volume] in Blood | 64.9 L | 70 - 140 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 16.2 | 7 - 45 | mg/dL |
| Creatinine [Mass/volume] in Blood | 0.8 | 0.6 - 1.1 | mg/dL |
| Calcium [Mass/volume] in Blood | 8.8 | 8.5 - 10.5 | mg/dL |
| Sodium [Moles/volume] in Blood | 142.7 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 4.0 | 3.5 - 5.1 | mmol/L |
| Chloride [Moles/volume] in Blood | 102.5 | 98 - 107 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 26.1 | 22 - 32 | mmol/L |
| Cholesterol [Mass/volume] in Serum or Plasma | 227.7 H | 125 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 124.8 | 0 - 150 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 157.1 H | 0 - 130 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 45.6 | 40 - 60 | mg/dL |
| Conclusion and Recommendations based on this report and previous findings known to us |
|---|
| The patient shows mildly elevated total and LDL cholesterol, indicating increased cardiovascular risk, while HDL and triglycerides are within normal limits. Hemoglobin A1c is at the upper end of normal, suggesting close monitoring for glucose metabolism is warranted. Glucose is slightly low, which may be due to fasting or other factors. Renal and electrolyte parameters are within normal ranges. Overall, lipid management and continued monitoring of glucose control are recommended. |